5 Oct 2026, 08:40
Company Update—
RADRADIOPHARM THERANOSTICS LIMITED
Announcement history available from 1 August 2025
Fromto
1 Oct 2026, 16:21
Securities Administration—
1 Oct 2026, 16:18
Director Interests—
30 Sept 2026, 16:24
Company Administration—
30 Sept 2026, 16:18
Financial Results—
22 Sept 2026, 14:13
Director Interests—
17 Sept 2026, 10:47
Securities Administration—
17 Sept 2026, 10:41
Securities Administration—
17 Sept 2026, 10:37
Securities Administration—
17 Sept 2026, 10:30
Securities Administration—
17 Sept 2026, 10:11
Capital Raising—
14 Sept 2026, 08:54
Company Update—
11 Sept 2026, 12:35
Meetings & Governance—
9 Sept 2026, 09:21
Company Update—
28 Aug 2026, 16:07
Financial ResultsMS
27 Aug 2026, 14:50
Director Interests—
26 Aug 2026, 08:59
Company UpdateMS
24 Aug 2026, 16:43
Substantial Holders—
20 Aug 2026, 08:51
Company UpdateMS
17 Aug 2026, 16:52
Substantial Holders—
17 Aug 2026, 09:02
Company UpdateMS
13 Aug 2026, 08:22
Meetings & Governance—
7 Aug 2026, 09:38
Capital Raising—
5 Aug 2026, 13:56
Securities Administration—
3 Aug 2026, 10:51
Securities Administration—
31 July 2026, 11:19
Quarterly ReportsMS
30 July 2026, 16:48
Substantial Holders—
30 July 2026, 16:32
Other—
30 July 2026, 16:25
Capital Raising—
28 July 2026, 16:19
Securities Administration—
28 July 2026, 10:53
Securities Administration—
24 July 2026, 17:21
ReinstatementMS
24 July 2026, 17:21
Capital Raising—
24 July 2026, 17:21
Securities Administration—
24 July 2026, 17:20
Securities Administration—
24 July 2026, 17:20
Capital RaisingMS
24 July 2026, 09:14
Trading Halt / SuspensionMS
22 July 2026, 09:04
Trading Halt / SuspensionMS
22 July 2026, 08:32
Company UpdateMS
22 July 2026, 08:22
Company UpdateMS
3 July 2026, 15:20
Periodic Reports—
30 June 2026, 16:15
Securities Administration—
30 June 2026, 16:05
Securities Administration—
3 June 2026, 12:08
Securities Administration—
1 May 2026, 09:53
Company Administration—
23 Apr 2026, 09:04
Quarterly ReportsMS
20 Apr 2026, 08:54
Company Update—
16 Apr 2026, 08:41
Company UpdateMS
8 Apr 2026, 09:00
Company UpdateMS
7 Apr 2026, 08:31
Company Update—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 08:40 | RAD Completes Meeting with US FDA for Development of RAD101 | Company Update | — | 11001 | |
| 1 Oct 2026, 16:21 | Notification of cessation of securities - RAD | Securities Administration | — | 06027 | |
| 1 Oct 2026, 16:18 | Change of Director's Interest Notice (RC) | Director Interests | — | 02009 | |
| 30 Sept 2026, 16:24 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 30 Sept 2026, 16:18 | Annual Report and Form 20-F | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 22 Sept 2026, 14:13 | Change of Director's Interest Notices x 4 | Director Interests | — | 02009 | |
| 17 Sept 2026, 10:47 | Notification regarding unquoted securities - RAD | Securities Administration | — | 06021 | |
| 17 Sept 2026, 10:41 | RADOC New Class Options Range of Units and Top 20 Holders | Securities Administration | — | 03002 | |
| 17 Sept 2026, 10:37 | Application for quotation of securities - RAD | Securities Administration | — | 06020 | |
| 17 Sept 2026, 10:30 | Application for quotation of securities - RAD | Securities Administration | — | 06020 | |
| 17 Sept 2026, 10:11 | Share purchase plan completed | Capital Raising | — | 06017 | |
| 14 Sept 2026, 08:54 | RAD oral presentation at SNO26 on RAD101 Phase IIb data | Company Update | — | 11001 | |
| 11 Sept 2026, 12:35 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 9 Sept 2026, 09:21 | RAD Announces Positive Data from RAD301 P1 Imaging Trial | Company Update | — | 11001 | |
| 28 Aug 2026, 16:07 | Appendix 4E and Preliminary Final Report | Financial Results | MS | 03003 | |
| 27 Aug 2026, 14:50 | Change of Director's Interest Notices x 4 | Director Interests | — | 02009 | |
| 26 Aug 2026, 08:59 | RAD Doses First Patient in Second Cohort of BetaBart (RV-01) | Company Update | MS | 11001 | |
| 24 Aug 2026, 16:43 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 20 Aug 2026, 08:51 | RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial | Company Update | MS | 11001 | |
| 17 Aug 2026, 16:52 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 Aug 2026, 09:02 | RAD to meet with US FDA to align on RAD 101 Phase 3 Trial | Company Update | MS | 11001 | |
| 13 Aug 2026, 08:22 | Notice of Extraordinary General Meeting and Proxy Form | Meetings & Governance | — | 08002, 08004 | |
| 7 Aug 2026, 09:38 | Share Purchase Plan - Now Open | Capital Raising | — | 06017, 16002 | |
| 5 Aug 2026, 13:56 | Update - Proposed issue of securities - RAD | Securities Administration | — | 06013 | |
| 3 Aug 2026, 10:51 | Application for quotation of securities - RAD | Securities Administration | — | 06020 | |
| 31 July 2026, 11:19 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 30 July 2026, 16:48 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 30 July 2026, 16:32 | Target market determination (TMD) | Other | — | 14001 | |
| 30 July 2026, 16:25 | Prospectus | Capital Raising | — | 06003, 06010, 06017, 16002 | |
| 28 July 2026, 16:19 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 28 July 2026, 10:53 | Application for quotation of securities - RAD | Securities Administration | — | 06020 | |
| 24 July 2026, 17:21 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 24 July 2026, 17:21 | Investor Presentation - Capital Raising | Capital Raising | — | 03026, 06003, 06009, 06017 | |
| 24 July 2026, 17:21 | Proposed issue of securities - RAD | Securities Administration | — | 06013 | |
| 24 July 2026, 17:20 | Proposed issue of securities - RAD | Securities Administration | — | 06013 | |
| 24 July 2026, 17:20 | RAD completes A$12.5 M placement and launches A$6 M SPP | Capital Raising | MS | 06003, 06009, 06017 | |
| 24 July 2026, 09:14 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 22 July 2026, 09:04 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 22 July 2026, 08:32 | RAD Achieves Partial Response in Phase 1 Trial of RAD204 | Company Update | MS | 11001 | |
| 22 July 2026, 08:22 | RAD Announces Positive Phase 2b Trial Results of RAD 101 | Company Update | MS | 11001 | |
| 3 July 2026, 15:20 | Radiopharm Receives $5.9M R&D Tax Incentive | Periodic Reports | — | 03014 | |
| 30 June 2026, 16:15 | Notification regarding unquoted securities - RAD | Securities Administration | — | 06021 | |
| 30 June 2026, 16:05 | Notification of cessation of securities - RAD | Securities Administration | — | 06027 | |
| 3 June 2026, 12:08 | Notification of cessation of securities - RAD | Securities Administration | — | 06027 | |
| 1 May 2026, 09:53 | Financial Services and Company Secretary Changes | Company Administration | — | 12007, 12008 | |
| 23 Apr 2026, 09:04 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 20 Apr 2026, 08:54 | RAD Initial Findings from Phase 1 177Lu-RAD202 Trial | Company Update | — | 11001, 12008 | |
| 16 Apr 2026, 08:41 | RAD Completes Enrollment in Phase 2b Trial of RAD 101 | Company Update | MS | 11001 | |
| 8 Apr 2026, 09:00 | RAD202 Phase 1 HEAT Trial Advances to Dose Level 3 | Company Update | MS | 11001 | |
| 7 Apr 2026, 08:31 | RAD and Siemens Sign Clinical Supply Agreement for RAD101 | Company Update | — | 11001 |
1–50 of 117
1 / 3